- €83.89m
- €170.38m
- €347.51m
- 69
- 82
- 46
- 76
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 176 | 226 | 233 | 267 | 348 |
Cost of Revenue | |||||
Gross Profit | 80.4 | 99.7 | 107 | 125 | 159 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 162 | 221 | 212 | 260 | 331 |
Operating Profit | 14 | 4.65 | 21.4 | 7.31 | 16.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 12.1 | 2.42 | 17.5 | 5.1 | 14.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 12.5 | 2.82 | 16.5 | 4.71 | 10.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 12.5 | 2.82 | 16.6 | 5.15 | 12.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 12.5 | 2.82 | 16.6 | 5.15 | 12.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.17 | 0.714 | 4.52 | 1.44 | 2.87 |
Dividends per Share | |||||
Special Dividends per Share |